BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 26390698)

  • 1. Upregulation of microRNA-224 sensitizes human cervical cells SiHa to paclitaxel.
    Lin F; Wang P; Shen Y; Xie X
    Eur J Gynaecol Oncol; 2015; 36(4):432-6. PubMed ID: 26390698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-375 is upregulated in acquired paclitaxel resistance in cervical cancer.
    Shen Y; Wang P; Li Y; Ye F; Wang F; Wan X; Cheng X; Lu W; Xie X
    Br J Cancer; 2013 Jul; 109(1):92-9. PubMed ID: 23778521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-126 Suppresses the proliferation of cervical cancer cells and alters cell sensitivity to the chemotherapeutic drug bleomycin.
    Yu Q; Liu SL; Wang H; Shi G; Yang P; Chen XL
    Asian Pac J Cancer Prev; 2014 Jan; 14(11):6569-72. PubMed ID: 24377569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paclitaxel inhibits the progression of cervical cancer by inhibiting autophagy via lncRNARP11-381N20.2.
    Zou SH; Du X; Lin H; Wang PC; Li M
    Eur Rev Med Pharmacol Sci; 2018 May; 22(10):3010-3017. PubMed ID: 29863245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential altered expression of let-7a and miR-205 tumor-suppressor miRNAs in different subtypes of breast cancer under treatment with Taxol.
    Asghari F; Haghnavaz N; Shanehbandi D; Khaze V; Baradaran B; Kazemi T
    Adv Clin Exp Med; 2018 Jul; 27(7):941-945. PubMed ID: 30019863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KRT17 confers paclitaxel-induced resistance and migration to cervical cancer cells.
    Li J; Chen Q; Deng Z; Chen X; Liu H; Tao Y; Wang X; Lin S; Liu N
    Life Sci; 2019 May; 224():255-262. PubMed ID: 30928404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of microtubule-associated protein tau (MAPT) by miR-34c-5p determines the chemosensitivity of gastric cancer to paclitaxel.
    Wu H; Huang M; Lu M; Zhu W; Shu Y; Cao P; Liu P
    Cancer Chemother Pharmacol; 2013 May; 71(5):1159-71. PubMed ID: 23423488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-34a Attenuates Paclitaxel Resistance in Prostate Cancer Cells via Direct Suppression of JAG1/Notch1 Axis.
    Liu X; Luo X; Wu Y; Xia D; Chen W; Fang Z; Deng J; Hao Y; Yang X; Zhang T; Zhou L; Wu Y; Wang Q; Xu J; Hu X; Li L
    Cell Physiol Biochem; 2018; 50(1):261-276. PubMed ID: 30282072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-101 regulates the viability and invasion of cervical cancer cells.
    Lin C; Huang F; Shen G; Yiming A
    Int J Clin Exp Pathol; 2015; 8(9):10148-55. PubMed ID: 26617722
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Hung PS; Chuang FJ; Chen CY; Chou CH; Tu HF; Lo SS
    Anticancer Res; 2020 Mar; 40(3):1427-1436. PubMed ID: 32132039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic anti-tumor effect of paclitaxel and miR-34a combined with ultrasound microbubbles on cervical cancer in vivo and in vitro.
    Yu J; Zhao Y; Liu C; Hu B; Zhao M; Ma Y; Jiang J
    Clin Transl Oncol; 2020 Jan; 22(1):60-69. PubMed ID: 31093891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human cancer cell line microRNAs associated with in vitro sensitivity to paclitaxel.
    Chen N; Chon HS; Xiong Y; Marchion DC; Judson PL; Hakam A; Gonzalez-Bosquet J; Permuth-Wey J; Wenham RM; Apte SM; Cheng JQ; Sellers TA; Lancaster JM
    Oncol Rep; 2014 Jan; 31(1):376-83. PubMed ID: 24220856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antagonism of miRNA-21 Sensitizes Human Gastric Cancer Cells to Paclitaxel.
    Jin B; Liu Y; Wang H
    Cell Biochem Biophys; 2015 May; 72(1):275-82. PubMed ID: 27040946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA 100 sensitizes luminal A breast cancer cells to paclitaxel treatment in part by targeting mTOR.
    Zhang B; Zhao R; He Y; Fu X; Fu L; Zhu Z; Fu L; Dong JT
    Oncotarget; 2016 Feb; 7(5):5702-14. PubMed ID: 26744318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-21 inhibitor suppresses cell proliferation and colony formation through regulating the PTEN/AKT pathway and improves paclitaxel sensitivity in cervical cancer cells.
    Du G; Cao D; Meng L
    Mol Med Rep; 2017 May; 15(5):2713-2719. PubMed ID: 28447761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergism between RIZ1 gene therapy and paclitaxel in SiHa cervical cancer cells.
    Cheng HY; Zhang T; Qu Y; Shi WJ; Lou G; Liu YX; Zhang YY; Cheng L
    Cancer Gene Ther; 2016 Nov; 23(11):392-395. PubMed ID: 27713401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of miR-203 sensitizes paclitaxel (Taxol)-resistant colorectal cancer cells through targeting the salt-inducible kinase 2 (SIK2).
    Liu Y; Gao S; Chen X; Liu M; Mao C; Fang X
    Tumour Biol; 2016 Sep; 37(9):12231-12239. PubMed ID: 27236538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Lentivirus media miR-1246 knockdown inhibits tumor growth and promotes apoptosis of SiHa cells].
    Du P; Lai YH; Yao DS; Lu Y; Chen JY; Ding N
    Zhonghua Fu Chan Ke Za Zhi; 2018 Jul; 53(7):481-486. PubMed ID: 30078258
    [No Abstract]   [Full Text] [Related]  

  • 19. MicroRNA-136 inhibits cancer stem cell activity and enhances the anti-tumor effect of paclitaxel against chemoresistant ovarian cancer cells by targeting Notch3.
    Jeong JY; Kang H; Kim TH; Kim G; Heo JH; Kwon AY; Kim S; Jung SG; An HJ
    Cancer Lett; 2017 Feb; 386():168-178. PubMed ID: 27887917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-1246 promotes SiHa cervical cancer cell proliferation, invasion, and migration through suppression of its target gene thrombospondin 2.
    Chen J; Yao D; Zhao S; He C; Ding N; Li L; Long F
    Arch Gynecol Obstet; 2014 Oct; 290(4):725-32. PubMed ID: 24806621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.